Cancer Cell International

Article	Citations
The role of hypoxia in the tumor microenvironment and development of cancer stem cell: a novel approach to developing treatment	361
New insights into M1/M2 macrophages: key modulators in cancer progression	248
p53 signaling in cancer progression and therapy	228
Challenges of applying multicellular tumor spheroids in preclinical phase	216
Anticancer potential of alkaloids: a key emphasis to colchicine, vinblastine, vincristine, vindesine, vinorelbine and vincamine	198
Chitosan nanoparticles as a promising tool in nanomedicine with particular emphasis on oncological treatment	167
Clinical applications of artificial intelligence and machine learning in cancer diagnosis: looking into the future	151
Combination therapy with immune checkpoint inhibitors (ICIs); a new frontier	115
The role of IGF2BP2, an m6A reader gene, in human metabolic diseases and cancers	107
Potential mechanisms of quercetin in cancer prevention: focus on cellular and molecular targets	95
RRM2 protects against ferroptosis and is a tumor biomarker for liver cancer	92
Dynamic regulation and functions of mRNA m6A modification	85
Ninjurin 2 rs118050317 gene polymorphism and endometrial cancer risk	84
Polyamines and related signaling pathways in cancer	79
Cancer-associated fibroblasts and resistance to anticancer therapies: status, mechanisms, and countermeasures	76
Integrated single-cell and bulk RNA sequencing analysis identifies a cancer associated fibroblast-related signature for predicting prognosis and therapeutic responses in colorectal cancer	74
Identification the ferroptosis-related gene signature in patients with esophageal adenocarcinoma	72
METTL3 promotes lung adenocarcinoma tumor growth and inhibits ferroptosis by stabilizing SLC7A11 m6A modification	72
Recent advances and limitations of mTOR inhibitors in the treatment of cancer	70
Emerging roles of RNA methylation in gastrointestinal cancers	69
Tumor-associated macrophage derived IL-6 enriches cancer stem cell population and promotes breast tumor progression via Stat-3 pathway	69
Induction and application of ferroptosis in cancer therapy	67
SCUBE3 downregulation modulates hepatocellular carcinoma by inhibiting CCNE1 via TGFβ/PI3K/AKT/GSK3β pathway	60
The biological function of m6A reader YTHDF2 and its role in human disease	58
Characterization of a ferroptosis and iron-metabolism related lncRNA signature in lung adenocarcinoma	56

Triple-negative breast cancer: understanding Wnt signaling in drug resistance	55
FTH promotes the proliferation and renders the HCC cells specifically resist to ferroptosis by maintaining iron homeostasis	55
Musashi-1 promotes cancer stem cell properties of glioblastoma cells via upregulation of YTHDF1	55
Exosome-transferred hsa_circ_0014235 promotes DDP chemoresistance and deteriorates the development of non-small cell lung cancer by mediating the miR-520a-5p/CDK4 pathway	54
The m6A methyltransferase METTL3 controls epithelial-mesenchymal transition, migration and invasion of breast cancer through the MALAT1/miR-26b/HMGA2 axis	54
Mesenchymal stem cells in cancer progression and anticancer therapeutic resistance	54
CAR-T cell combination therapy: the next revolution in cancer treatment	53
Exosomal lncRNA SNHG10 derived from colorectal cancer cells suppresses natural killer cell cytotoxicity by upregulating INHBC	53
Recent advances in non-small cell lung cancer targeted therapy; an update review	52
Apigenin role as cell-signaling pathways modulator: implications in cancer prevention and treatment	52
Cancer immunotherapy with immune checkpoint inhibitors (ICIs): potential, mechanisms of resistance, and strategies for reinvigorating T cell responsiveness when resistance is acquired	51
Potential of antibody–drug conjugates (ADCs) for cancer therapy	51
Myricetin: targeting signaling networks in cancer and its implication in chemotherapy	51
Morphological and molecular characteristics of spheroid formation in HT-29 and Caco-2 colorectal cancer cell lines	50
Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma	50
Anti-tumor activity of resveratrol against gastric cancer: a review of recent advances with an emphasis on molecular pathways	49
Cancer-related circular RNA: diverse biological functions	48
An updated review of mechanistic potentials of melatonin against cancer: pivotal roles in angiogenesis, apoptosis, autophagy, endoplasmic reticulum stress and oxidative stress	48
Strategies to overcome the main challenges of the use of exosomes as drug carrier for cancer therapy	45
Small molecule inhibitors against PD-1/PD-L1 immune checkpoints and current methodologies for their development: a review	45
Emerging cellular and molecular mechanisms underlying anticancer indications of chrysin	45
Critical signaling pathways governing hepatocellular carcinoma behavior; small molecule-based approaches	45
Autophagy regulation using luteolin: new insight into its anti-tumor activity	44
Biological causes of immunogenic cancer cell death (ICD) and anti-tumor therapy; Combination of Oncolytic virus-based immunotherapy and CAR T-cell therapy for ICD induction	43
Resveratrol, curcumin, paclitaxel and miRNAs mediated regulation of PI3K/Akt/mTOR pathway: go four better to treat bladder cancer	43
Signaling pathways of EBV-induced oncogenesis	42
Circular RNA hsa_circ_0003288 induces EMT and invasion by regulating hsa_circ_0003288/miR-145/PD-L1 axis in hepatocellular carcinoma	42
Mitophagy in carcinogenesis, drug resistance and anticancer therapeutics	42
Macrophages-derived exosomal lncRNA LIFR-AS1 promotes osteosarcoma cell progression via miR-29a/NFIA axis	42
Mesenchymal stem cells and cancer therapy: insights into targeting the tumour vasculature	42
BRD4 PROTAC degrader ARV-825 inhibits T-cell acute lymphoblastic leukemia by targeting 'Undruggable' Myc-pathway genes	42
Therapeutic potentials of resveratrol in combination with radiotherapy and chemotherapy during glioblastoma treatment: a mechanistic review	41
MicroRNAs and angiogenesis: a new era for the management of colorectal cancer	41
The dysbiosis signature of Fusobacterium nucleatum in colorectal cancer-cause or consequences? A systematic review	40
Ovarian cancer: epigenetics, drug resistance, and progression	40
LncRNA SNHG3, a potential oncogene in human cancers	40
Genistein as a regulator of signaling pathways and microRNAs in different types of cancers	40
Role of m6A methyltransferase component VIRMA in multiple human cancers (Review)	39
Identification of collagen genes related to immune infiltration and epithelial-mesenchymal transition in glioma	39
A systematic review of anti-cancer roles and mechanisms of kaempferol as a natural compound	38
The regulatory role of antisense lncRNAs in cancer	37
Knockdown lncRNA CRNDE enhances temozolomide chemosensitivity by regulating autophagy in glioblastoma	37
Intrahepatic cholangiocarcinoma induced M2-polarized tumor-associated macrophages facilitate tumor growth and invasiveness	37
Long non-coding RNAs as the critical regulators of epithelial mesenchymal transition in colorectal tumor cells: an overview	37
Anticancer effects of bifidobacteria on colon cancer cell lines	37
A review on the role of cyclin dependent kinases in cancers	36
LncRNA LIFR-AS1 promotes proliferation and invasion of gastric cancer cell via miR-29a-3p/COL1A2 axis	36
CAFs affect the proliferation and treatment response of head and neck cancer spheroids during co-culturing in a unique in vitro model	36
The cancer‐associated fibroblasts related gene CALD1 is a prognostic biomarker and correlated with immune infiltration in bladder cancer	35
Luteolin: a flavonoid with a multifaceted anticancer potential	35

Oncolytic virotherapy reverses the immunosuppressive tumor microenvironment and its potential in combination with immunotherapy	35
CircRNA PIP5K1A promotes the progression of glioma through upregulation of the TCF12/PI3K/AKT pathway by sponging miR-515-5p	35
A systematic review of the therapeutic effects of resveratrol in combination with 5-fluorouracil during colorectal cancer treatment: with a special focus on the oxidant, apoptotic, and anti-inflammato	35
MicroRNA-122 in human cancers: from mechanistic to clinical perspectives	35
The diagnostic value of EBV-DNA and EBV-related antibodies detection for nasopharyngeal carcinoma: a meta-analysis	35
Circ_ZFR contributes to the paclitaxel resistance and progression of non-small cell lung cancer by upregulating KPNA4 through sponging miR-195-5p	35
Chemoprotective and chemosensitizing effects of apigenin on cancer therapy	34
The role of Th17 cells in the pathogenesis and treatment of breast cancer	34
A review on the advances and challenges of immunotherapy for head and neck cancer	34
Automatic model for cervical cancer screening based on convolutional neural network: a retrospective, multicohort, multicenter study	34
Long non-coding RNA NORAD contributes to the proliferation, invasion and EMT progression of prostate cancer via the miR-30a-5p/RAB11A/WNT/β-catenin pathway	33
MicroRNAs as the critical regulators of Doxorubicin resistance in breast tumor cells	33
Circular RNA hsa_circ_0061395 accelerates hepatocellular carcinoma progression via regulation of the miR-877-5p/PIK3R3 axis	33
The effects of several postoperative adjuvant therapies for hepatocellular carcinoma patients with microvascular invasion after curative resection: a systematic review and meta-analysis	33
CRISPR/Cas9 system in breast cancer therapy: advancement, limitations and future scope	32
Establishment and validation of a prognostic signature for lung adenocarcinoma based on metabolism‐related genes	32
RETRACTED ARTICLE: Berberine reduces temozolomide resistance by inducing autophagy via the ERK1/2 signaling pathway in glioblastoma	32
RNA m6A methylation regulators in ovarian cancer	32
Mismatch repair-deficient hormone receptor-positive breast cancers: Biology and pathological characterization	31
Curcumin anti‐tumor effects on endometrial cancer with focus on its molecular targets	31
Periostin: biology and function in cancer	31
Exosomal miR-301a-3p from esophageal squamous cell carcinoma cells promotes angiogenesis by inducing M2 polarization of macrophages via the PTEN/PI3K/AKT signaling pathway	31
CD44, a marker of cancer stem cells, is positively correlated with PD-L1 expression and immune cells infiltration in lung adenocarcinoma	31
A novel prognostic model based on single-cell RNA sequencing data for hepatocellular carcinoma	31
Role of glutamine and its metabolite ammonia in crosstalk of cancer-associated fibroblasts and cancer cells	31
Exosomes from tamoxifen-resistant breast cancer cells transmit drug resistance partly by delivering miR-9-5p	31
LncRNA WDFY3-AS2 promotes cisplatin resistance and the cancer stem cell in ovarian cancer by regulating hsa-miR-139-5p/SDC4 axis	31
M2 macrophages secrete CXCL13 to promote renal cell carcinoma migration, invasion, and EMT	31
Exosomes derived from M2 type tumor-associated macrophages promote osimertinib resistance in non-small cell lung cancer through MSTRG.292666.16-miR-6836-5p-MAPK8IP3 axis	30
Crosstalk between tumor-associated macrophages and tumor cells promotes chemoresistance via CXCL5/PI3K/AKT/mTOR pathway in gastric cancer	30
Assessing immune infiltration and the tumor microenvironment for the diagnosis and prognosis of sarcoma	30
Molecular mechanisms of the microRNA-132 during tumor progressions	30
Engineered exosomes loaded with miR-449a selectively inhibit the growth of homologous non-small cell lung cancer	30
Deciphering molecular mechanisms underlying chemoresistance in relapsed AML patients: towards precision medicine overcoming drug resistance	30
Crosstalk between MUC1 and VEGF in angiogenesis and metastasis: a review highlighting roles of the MUC1 with an emphasis on metastatic and angiogenic signaling	30
The expression profiles and prognostic values of HSP70s in hepatocellular carcinoma	30
NAT10 as a potential prognostic biomarker and therapeutic target for HNSCC	30
Current methods for studying metastatic potential of tumor cells	29
Elevated exosome-derived miRNAs predict osimertinib resistance in non-small cell lung cancer	29
MALAT1-related signaling pathways in colorectal cancer	29
Targeting Ras-ERK cascade by bioactive natural products for potential treatment of cancer: an updated overview	29
Tumor microenvironment in ovarian cancer peritoneal metastasis	29
Prognostic impact of tertiary lymphoid structures in breast cancer prognosis: a systematic review and meta-analysis	29
Resveratrol mediates its anti-cancer effects by Nrf2 signaling pathway activation	29
Sesquiterpenoid lactones as potential anti-cancer agents: an update on molecular mechanisms and recent studies	29
Modulation of the tumour microenvironment in hepatocellular carcinoma by tyrosine kinase inhibitors: from modulation to combination therapy targeting the microenvironment	29
Inhibition of cancer cell-derived exosomal microRNA-183 suppresses cell growth and metastasis in prostate cancer by upregulating TPM1	28
circ_NRIP1 is oncogenic in malignant development of esophageal squamous cell carcinoma (ESCC) via miR-595/SEMA4D axis and PI3K/AKT pathway	28
Ferroptosis-related gene signature predicts the prognosis of papillary thyroid carcinoma	28
Notch-associated lncRNAs profiling circuiting epigenetic modification in colorectal cancer	28
Roles of ferroptosis in urologic malignancies	28
Advances in biomarkers and techniques for pancreatic cancer diagnosis	28
CircRNA_100290 promotes GC cell proliferation and invasion via the miR-29b-3p/ITGA11 axis and is regulated by EIF4A3	28
Identification and validation of lncRNAs involved in m6A regulation for patients with ovarian cancer	28
A review on the role of mir-16-5p in the carcinogenesis	28
Exosomes from cervical cancer cells facilitate pro-angiogenic endothelial reconditioning through transfer of Hedgehog–GLI signaling components	28
Cancer and diabetes: the interlinking metabolic pathways and repurposing actions of antidiabetic drugs	27
Emerging roles for lncRNA-NEAT1 in colorectal cancer	27
M2 macrophages‐derived exosomal microRNA-501-3p promotes the progression of lung cancer via targeting WD repeat domain 82	27
Long non-coding RNA LINC00470 in serum derived exosome: a critical regulator for proliferation and autophagy in glioma cells	27
Biosensing chips for cancer diagnosis and treatment: a new wave towards clinical innovation	27
Circular RNA circ_0006168 enhances Taxol resistance in esophageal squamous cell carcinoma by regulating miR-194-5p/JMJD1C axis	27
Development and clinical validation of a novel six-gene signature for accurately predicting the recurrence risk of patients with stage II/III colorectal cancer	27
The plasma exosomal miR-1180-3p serves as a novel potential diagnostic marker for cutaneous melanoma	27
LPCAT1 overexpression promotes the progression of hepatocellular carcinoma	26
Prognostic role of METTL1 in glioma	26
The lncRNA NEAT1 promotes the epithelial-mesenchymal transition and metastasis of osteosarcoma cells by sponging miR-483 to upregulate STAT3 expression	26
Circ_0015756 promotes the progression of ovarian cancer by regulating miR-942-5p/CUL4B pathway	26
YTHDC1-mediated VPS25 regulates cell cycle by targeting JAK-STAT signaling in human glioma cells	26
Multi-omics analysis reveals prognostic value of tumor mutation burden in hepatocellular carcinoma	26
FOXM1 modulates docetaxel resistance in prostate cancer by regulating KIF20A	25
LncRNA HOTAIR promotes proliferation and inhibits apoptosis by sponging miR-214-3p in HPV16 positive cervical cancer cells	25
Hsa_circ_0010235 functions as an oncogenic drive in non-small cell lung cancer by modulating miR-433-3p/TIPRL axis	25
LINC00152 upregulates ZEB1 expression and enhances epithelial-mesenchymal transition and oxaliplatin resistance in esophageal cancer by interacting with EZH2	25
Prognostic biomarker TUBA1C is correlated to immune cell infiltration in the tumor microenvironment of lung adenocarcinoma	25
As a biomarker for gastric cancer, circPTPN22 regulates the progression of gastric cancer through the EMT pathway	25
Targeting Nrf2 may reverse the drug resistance in ovarian cancer	25
Exosomal circRNA as a novel potential therapeutic target for multiple myeloma-related myocardial damage	24
Verteporfin disrupts multiple steps of autophagy and regulates p53 to sensitize osteosarcoma cells	24
SGLT2 inhibition restrains thyroid cancer growth via G1/S phase transition arrest and apoptosis mediated by DNA damage response signaling pathways	24

CircFBXL5 promotes the 5-FU resistance of breast cancer via modulating miR-216b/HMGA2 axis	24
Tumor-infiltrating B cells as a favorable prognostic biomarker in breast cancer: a systematic review and meta-analysis	24
Role of PRKDC in cancer initiation, progression, and treatment	24
Post treatment NLR is a predictor of response to immune checkpoint inhibitor therapy in patients with esophageal squamous cell carcinoma	24
Disulfidptosis-associated long non-coding RNA signature predicts the prognosis, tumor microenvironment, and immunotherapy and chemotherapy options in colon adenocarcinoma	24
The importance of CDC27 in cancer: molecular pathology and clinical aspects	24
Application of HER2 peptide vaccines in patients with breast cancer: a systematic review and meta-analysis	24
Fatty acid oxidation: driver of lymph node metastasis	24
LncRNA HOXA-AS3 promotes gastric cancer progression by regulating miR-29a-3p/LTβR and activating NF-κB signaling	24
STAT3 pathway as a molecular target for resveratrol in breast cancer treatment	23
MicroRNA-550a-3-5p controls the brain metastasis of lung cancer by directly targeting YAP1	23
Targeted nanobody complex enhanced photodynamic therapy for lung cancer by overcoming tumor microenvironment	23
Decreased expression of METTL14 predicts poor prognosis and construction of a prognostic signature for clear cell renal cell carcinoma	23
Relationship between PD-L1 expression, CD8+ T-cell infiltration and prognosis in intrahepatic cholangiocarcinoma patients	23
Anti-cancer properties of quercetin in osteosarcoma	23
Correlation of CCL8 expression with immune cell infiltration of skin cutaneous melanoma: potential as a prognostic indicator and therapeutic pathway	23
Blocking circ-SCMH1 (hsa_circ_0011946) suppresses acquired DDP resistance of oral squamous cell carcinoma (OSCC) cells both in vitro and in vivo by sponging miR-338-3p and regulating LIN28B	23
RETRACTED ARTICLE: GPX8 is transcriptionally regulated by FOXC1 and promotes the growth of gastric cancer cells through activating the Wnt signaling pathway	23
Systematic analysis of the expression and prognosis relevance of FBXO family reveals the significance of FBXO1 in human breast cancer	23
TBX15/miR-152/KIF2C pathway regulates breast cancer doxorubicin resistance via promoting PKM2 ubiquitination	23
Targeted intervention of eIF4A1 inhibits EMT and metastasis of pancreatic cancer cells via c-MYC/miR-9 signaling	23
LncRNA HOXA-AS2 promotes glioblastoma carcinogenesis by targeting miR-885-5p/RBBP4 axis	22
CDCA8 as an independent predictor for a poor prognosis in liver cancer	22
NCAPG facilitates colorectal cancer cell proliferation, migration, invasion and epithelial–mesenchymal transition by activating the Wnt/β-catenin signaling pathway	22
Circular RNA circWWC3 augments breast cancer progression through promoting M2 macrophage polarization and tumor immune escape via regulating the expression and secretion of IL-4	22
SNHG17 promotes the proliferation and migration of colorectal adenocarcinoma cells by modulating CXCL12-mediated angiogenesis	22
Ursolic acid: a natural modulator of signaling networks in different cancers	22
Role of LncRNAs in regulating cancer amino acid metabolism	22
LncRNA CBR3-AS1 potentiates Wnt/β-catenin signaling to regulate lung adenocarcinoma cells proliferation, migration and invasion	22
Parthenolide inhibits the growth of non-small cell lung cancer by targeting epidermal growth factor receptor	22
HHLA2 predicts better survival and exhibits inhibited proliferation in epithelial ovarian cancer	22
The current issues and future perspective of artificial intelligence for developing new treatment strategy in non-small cell lung cancer: harmonization of molecular cancer biology and artificial intel	22
Hormonal regulation of telomerase activity and hTERT expression in steroid-regulated tissues and cancer	22
ADAM10 is involved in the oncogenic process and chemo-resistance of triple-negative breast cancer via regulating Notch1 signaling pathway, CD44 and PrPc	22
Hydrogen inhibits the proliferation and migration of gastric cancer cells by modulating lncRNA MALAT1/miR-124-3p/EZH2 axis	22
lncRNA APOC1P1-3 promoting anoikis-resistance of breast cancer cells	22
Long noncoding RNA SNHG4: a novel target in human diseases	22
Myc-associated zinc-finger protein promotes clear cell renal cell carcinoma progression through transcriptional activation of the MAP2K2-dependent ERK pathway	21
Exosomal miR-126 blocks the development of non-small cell lung cancer through the inhibition of ITGA6	21
Ten-gene signature reveals the significance of clinical prognosis and immuno-correlation of osteosarcoma and study on novel skeleton inhibitors regarding MMP9	21
Clinical and prognostic significances of cancer stem cell markers in gastric cancer patients: a systematic review and meta-analysis	21
miR-133a targets YES1 to reduce cisplatin resistance in ovarian cancer by regulating cell autophagy	21
NCAPG promotes the progression of lung adenocarcinoma via the TGF-β signaling pathway	21
Circular RNA circPLK1 promotes breast cancer cell proliferation, migration and invasion by regulating miR-4500/IGF1 axis	21
CAR-NKT cell therapy: a new promising paradigm of cancer immunotherapy	21
Exploring the oncostatin M (OSM) feed-forward signaling of glioblastoma via STAT3 in pan-cancer analysis	21
Pan-cancer analysis combined with experiments predicts CTHRC1 as a therapeutic target for human cancers	21
RETRACTED ARTICLE: LncRNA LBX2-AS1 promotes colorectal cancer progression and 5-fluorouracil resistance	21
RETRACTED ARTICLE: LncRNA SNHG12 regulates the radiosensitivity of cervical cancer through the miR-148a/CDK1 pathway	21
Identification of an immune gene signature for predicting the prognosis of patients with uterine corpus endometrial carcinoma	21
Alpha-1-antichymotrypsin as a novel biomarker for diagnosis, prognosis, and therapy prediction in human diseases	21
Hypoxia-mediated YTHDF2 overexpression promotes lung squamous cell carcinoma progression by activation of the mTOR/AKT axis	21
Metformin exerts anti-AR-negative prostate cancer activity via AMPK/autophagy signaling pathway	21
BMI1 promotes osteosarcoma proliferation and metastasis by repressing the transcription of SIK1	21
Bacteria‐derived ferrichrome inhibits tumor progression in sporadic colorectal neoplasms and colitis‐associated cancer	21
Circular RNA circCSPP1 knockdown attenuates doxorubicin resistance and suppresses tumor progression of colorectal cancer via miR-944/FZD7 axis	21
A novel signature constructed by ferroptosis-associated genes (FAGs) for the prediction of prognosis in bladder urothelial carcinoma (BLCA) and associated with immune infiltration	21
Silenced lncRNA SNHG14 restrains the biological behaviors of bladder cancer cells via regulating microRNA-211-3p/ESM1 axis	21
Identification and development of a novel invasion-related gene signature for prognosis prediction in colon adenocarcinoma	20
DNMT1 facilitates growth of breast cancer by inducing MEG3 hyper-methylation	20
Tumor microenvironment: a prospective target of natural alkaloids for cancer treatment	20
The molecular mechanism of METTL3 promoting the malignant progression of lung cancer	20
A pan-cancer analysis of molecular characteristics and oncogenic role of gasdermins	20
Cervical cancer-derived exosomal miR-663b promotes angiogenesis by inhibiting vinculin expression in vascular endothelial cells	20
Targeting SNHG3/miR-186-5p reverses the increased m6A level caused by platinum treatment through regulating METTL3 in esophageal cancer	20
Exosome-based strategies for diagnosis and therapy of glioma cancer	20
Circ-RNF121 regulates tumor progression and glucose metabolism by miR-1224-5p/FOXM1 axis in colorectal cancer	20
Apoptosis evasion via long non-coding RNAs in colorectal cancer	20
LncRNA TP73‐AS1 promotes nasopharyngeal carcinoma progression through targeting miR-342-3p and M2 polarization via exosomes	20
Midkine promotes glioblastoma progression via PI3K-Akt signaling	20
Influence of icariin on inflammation, apoptosis, invasion, and tumor immunity in cervical cancer by reducing the TLR4/MyD88/NF-κB and Wnt/β-catenin pathways	20
Human drug efflux transporter ABCC5 confers acquired resistance to pemetrexed in breast cancer	20
Overexpression of CBS/H2S inhibits proliferation and metastasis of colon cancer cells through downregulation of CD44	20
LncRNA MEG8 promotes NSCLC progression by modulating the miR-15a-5p-miR-15b-5p/PSAT1 axis	20
The effective function of circular RNA in colorectal cancer	20
Identification and validation of a pyroptosis-related prognostic signature for thyroid cancer	20
UTRN inhibits melanoma growth by suppressing p38 and JNK/c-Jun signaling pathways	20
hnRNPA2B1 regulates the alternative splicing of BIRC5 to promote gastric cancer progression	20
Disease-associated regulation of gene expression by resveratrol: Special focus on the PI3K/AKT signaling pathway	20
Current understanding of epigenetics role in melanoma treatment and resistance	20
Recombinant immunotoxins development for HER2-based targeted cancer therapies	20
Circular RNA hsa_circ_0044234 as distinct molecular signature of triple negative breast cancer: a potential regulator of GATA3	19
YAP manipulates proliferation via PTEN/AKT/mTOR-mediated autophagy in lung adenocarcinomas	19
Let-7a induces metabolic reprogramming in breast cancer cells via targeting mitochondrial encoded ND4	19
Identification and validation of a novel glycolysis-related gene signature for predicting the prognosis in ovarian cancer	19
Plasma tRNA-derived small RNAs signature as a predictive and prognostic biomarker in lung adenocarcinoma	19
Gly-tRF enhances LCSC-like properties and promotes HCC cells migration by targeting NDFIP2	19
Protopine triggers apoptosis via the intrinsic pathway and regulation of ROS/PI3K/Akt signalling pathway in liver carcinoma	19
TRIM47 promotes malignant progression of renal cell carcinoma by degrading P53 through ubiquitination	19
Circ-SFMBT2 drives the malignant phenotypes of esophageal cancer by the miR-107-dependent regulation of SLC1A5	19
The role of LncRNAs in tumor immunotherapy	19
LINC00958 promotes the proliferation of TSCC via miR-211-5p/CENPK axis and activating the JAK/STAT3 signaling pathway	19
EZR promotes pancreatic cancer proliferation and metastasis by activating FAK/AKT signaling pathway	19
Estrogen/ER in anti-tumor immunity regulation to tumor cell and tumor microenvironment	19
PPP2R2B downregulation is associated with immune evasion and predicts poor clinical outcomes in triple-negative breast cancer	19